Prevalence and molecular characterization of extended-spectrum-β-lactamase-producing Enterobacteriaceae in a pediatric patient population.
about
Beyond Susceptible and Resistant, Part II: Treatment of Infections Due to Gram-Negative Organisms Producing Extended-Spectrum β-LactamasesEscherichia coli ST131, an intriguing clonal groupGlobal assessment of antimicrobial susceptibility among Gram-negative organisms collected from pediatric patients between 2004 and 2012: results from the Tigecycline Evaluation and Surveillance TrialExtended-spectrum β-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat.Antimicrobial susceptibility pattern of extended-spectrum beta- lactamase producing Klebsiella pneumoniae clinical isolates in an Indian tertiary hospital.Prevalence of MDR pathogens of bacterial meningitis in Egypt and new synergistic antibiotic combinationsGut Colonization of Healthy Children and Their Mothers With Pathogenic Ciprofloxacin-Resistant Escherichia coli.Prevalence and characterization of extended-spectrum beta-lactamases producing Enterobacteriaceae in healthy children and associated risk factors.The Prevalence and Molecular Epidemiology of Multidrug-Resistant Enterobacteriaceae Colonization in a Pediatric Intensive Care Unit.Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131.The Antimicrobial Susceptibility of Klebsiella pneumoniae from Community Settings in Taiwan, a Trend Analysis.Escherichia coli sequence type 131: epidemiology and challenges in treatment.Incidence and Outcomes of Infections Caused by Multidrug-Resistant Enterobacteriaceae in Children, 2007-2015.CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains.An Improved Extended-Spectrum-β-Lactamase Detection Test Utilizing Aztreonam plus Clavulanate.Relationship between β-lactamase production and resistance phenotype in Klebsiella pneumoniae strains.Prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae: first systematic meta-analysis report from Pakistan.Extended-spectrum β-lactamase & carbapenemase-producing Gram-negative bacilli in neonates from a tertiary care centre in Dibrugarh, Assam, India.Molecular characterization of extended spectrum β -lactamases enterobacteriaceae causing lower urinary tract infection among pediatric populationAntibiotic resistance pattern and molecular characterization of extended-spectrum β-lactamase producing enteroaggregative isolates in children from southwest Iran
P2860
Q28249617-0F599415-05D6-4DDC-A717-B826833E8DD8Q34057648-61BB7650-ACBC-463B-868D-23F7DBECFB20Q35193312-F290498D-1BA6-4B1F-8D83-4A85099AB311Q35555196-29688D1F-7807-4B2F-9FB1-BFB7DC53C666Q35993387-F74BA19C-2DC9-4894-ABAA-AA901FE3B1C2Q36282516-41589145-B917-4B0F-BD3D-3C4D42BB52DCQ36306912-CB72C3C6-2821-4438-AC7D-F9A308068033Q36517575-7D170315-550D-40BB-AD64-6CDB72B522C9Q36803345-9948BC2F-9CC3-42CB-BDFB-3384B74CFFE1Q37026386-F1D0B8BF-BC28-4698-B8C2-A004108AB658Q37400286-05F1A765-C8F1-4625-8839-AD36C3CC0E93Q38201515-F313D82F-03EF-42E2-8090-4DAC7E3C8465Q38878895-A87391AB-C916-409A-8827-469B9B5E748AQ41480033-12201FF2-529F-4522-93CE-A60AF70EC8E5Q46949126-37D47240-A239-4EF1-80CA-63FFB891CCD6Q50091340-1313F879-3F96-4233-A55A-7739F0CCECD6Q50848814-1FD51DF0-29CA-41B3-921F-7207770A733CQ51409908-CC3DA2AE-2C35-45E6-941F-21EE24F3FACFQ55000061-E7990D3C-A7D1-4081-A3A4-A8DC7777A9CCQ56517171-396EBE6B-4A28-4021-B23C-782EBB8F47E8Q57945243-C5081DDB-0250-4927-B9E7-616C1CD7B849
P2860
Prevalence and molecular characterization of extended-spectrum-β-lactamase-producing Enterobacteriaceae in a pediatric patient population.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Prevalence and molecular chara ...... pediatric patient population.
@ast
Prevalence and molecular chara ...... pediatric patient population.
@en
type
label
Prevalence and molecular chara ...... pediatric patient population.
@ast
Prevalence and molecular chara ...... pediatric patient population.
@en
prefLabel
Prevalence and molecular chara ...... pediatric patient population.
@ast
Prevalence and molecular chara ...... pediatric patient population.
@en
P2860
P356
P1476
Prevalence and molecular chara ...... pediatric patient population.
@en
P2093
Lakshmi Chandramohan
Paula A Revell
P2860
P304
P356
10.1128/AAC.00666-12
P407
P577
2012-06-25T00:00:00Z